Lifestyle Modification for Diabetic Neuropathy
(IMABIN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a personalized program of diet, physical activity, and balance exercises (lifestyle modification) can improve nerve function and balance in people with early-stage type 2 diabetes or prediabetes. The researchers aim to determine if these lifestyle changes can reduce symptoms like dizziness or cold feet and lower the risk of falls. Participants will follow a tailored plan of aerobic exercises and balance training to assess improvements in quality of life. This trial is suitable for individuals with impaired glucose regulation (early-stage diabetes or prediabetes) who experience symptoms such as dizziness, dry mouth, or balance issues.
As an unphased trial, this study provides an opportunity to contribute to understanding how lifestyle changes can improve health outcomes.
Will I have to stop taking my current medications?
The trial does not require you to stop taking your current medications. However, if you are on diabetes medication, you need to have been stable on it for at least 3 months before joining the study.
What prior data suggests that this lifestyle modification is safe for improving autonomic function and balance in individuals with impaired glucose regulation?
Research has shown that lifestyle changes, such as diet and exercise, are generally safe and low-risk for individuals with diabetic nerve pain. Studies have found that these changes offer many benefits with minimal risk. Participants in these programs often experience improved health without serious side effects.
Exercise, particularly activities like walking or cycling, is associated with better nerve health and fewer complications. This type of exercise is safe and can help slow nerve damage.
Additionally, programs that incorporate exercise and dietary changes have proven helpful for people with diabetes, improving symptoms and overall health. These programs are tailored to each individual, making them both safe and effective for managing diabetic nerve pain.
In summary, lifestyle changes are well-tolerated and provide a safe way to potentially enhance health for those with diabetic nerve pain.12345Why are researchers excited about this trial?
Most treatments for diabetic neuropathy focus on managing symptoms with medications like pain relievers or antidepressants. However, researchers are excited about this trial because it emphasizes a holistic approach through lifestyle modification. The Diet, Physical Activity, and Balance Enhancement Program (DPAEP) is unique because it provides a personalized plan that combines structured weight loss, weight maintenance, and aerobic exercise tailored to individual needs. This approach not only targets weight and fitness but also aims to improve autonomic function, potentially offering benefits beyond what current medication can achieve. By focusing on meaningful, personalized activities and consistent support, this treatment could lead to improved overall health and quality of life for patients.
What evidence suggests that lifestyle modification might be an effective treatment for diabetic neuropathy?
Research has shown that lifestyle changes, such as exercising and eating a healthy diet, can aid individuals with diabetic nerve damage. In this trial, participants in the Diet, Physical Activity, and Balance Enhancement Program (DPAEP) group will follow a structured weight loss and aerobic exercise program. One study found that these changes can slow the progression of nerve damage in people with diabetes. Another study demonstrated that aerobic exercise, such as walking or cycling, can enhance nerve function. These lifestyle changes can also improve balance, which is crucial for preventing falls. Overall, these changes offer a promising approach to managing symptoms and improving the quality of life for those with early diabetes or blood sugar control issues.12367
Who Is on the Research Team?
James W Russell, MD
Principal Investigator
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Are You a Good Fit for This Trial?
This trial is for adults aged 30-80 with diabetic neuropathy due to impaired glucose regulation, including prediabetes and early diabetes. Participants must not be pregnant or imprisoned, have stable medical conditions, and agree to use contraception if applicable. They should not have severe autonomic neuropathy that limits participation in the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Testing
Participants undergo baseline testing before randomization into study groups
Treatment
Participants in the DPAEP group undergo a structured weight loss and maintenance program, along with aerobic exercise for 12 months. The SC group receives general diet and physical activity information.
Follow-up
Participants are monitored for changes in autonomic function and balance control after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- lifestyle modification
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor